Pancreas transplant – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 10:51:19 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Pancreas transplant – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of anakinra and a drug combination to prevent blood clots in patients receiving a pancreatic transplant https://clinicaltrials.eu/trial/study-of-anakinra-and-a-drug-combination-to-prevent-blood-clots-in-patients-receiving-a-pancreatic-transplant/ Wed, 27 May 2026 04:05:18 +0000 https://clinicaltrials.eu/trial/study-of-anakinra-and-a-drug-combination-to-prevent-blood-clots-in-patients-receiving-a-pancreatic-transplant/ This study focuses on individuals who have undergone a pancreatic transplant, which is a surgical procedure to replace a damaged pancreas with a healthy organ from a donor. The goal of the study is to evaluate the safety of using anakinra to prevent immunothrombosis, a process where the immune system causes blood clots to form within an organ. Participants in the study may also be taking background medications such as etanercept, mycophenolic acid, or tacrolimus to help prevent the body from attacking the new organ.

During the study, the focus is on monitoring how the body responds to the new organ and the medications over the first year. This includes observing for signs of rejection, which occurs when the immune system identifies the transplanted organ as foreign and tries to destroy it. The study also tracks the occurrence of various infections and monitors how well the new pancreas functions by checking blood sugar levels and the need for insulin.

]]> Study on Organ Preservation in Kidney, Liver, and Pancreas Transplants Using Custodiol-N Solution Compared to a Drug Combination for Transplant Patients https://clinicaltrials.eu/trial/study-on-organ-preservation-in-kidney-liver-and-pancreas-transplants-using-custodiol-n-solution-compared-to-a-drug-combination-for-transplant-patients/ Wed, 29 Apr 2026 14:22:47 +0000 https://clinicaltrials.eu/trial/study-on-organ-preservation-in-kidney-liver-and-pancreas-transplants-using-custodiol-n-solution-compared-to-a-drug-combination-for-transplant-patients/ This clinical trial is focused on studying the effectiveness of two solutions used in organ transplantation, specifically for the kidney, liver, and pancreas. The trial compares a new solution called Custodiol-N with an existing solution known as Custodiol. These solutions are used to preserve organs before they are transplanted into patients. The main goal of the study is to determine if Custodiol-N is as effective as Custodiol in maintaining the function and health of the transplanted organs.

Participants in the study will be patients undergoing organ transplants. The study will involve the use of either Custodiol-N or Custodiol during the organ preservation process. The trial will monitor the function of the transplanted organs and any potential injuries that may occur after the transplantation. The study will also track various health indicators over a period of time to assess the success of the organ transplants.

The trial is designed to be prospective, meaning it will follow patients over time to observe outcomes. It is also randomized, which means participants will be randomly assigned to receive either Custodiol-N or Custodiol. The study is single-blind, so the patients will not know which solution they are receiving, but the researchers will. This approach helps ensure that the results are unbiased and reliable. The study is expected to continue until the end of 2025.

]]>